If the World Trade Organization gets its way, an IP waiver deal for Covid-19 vaccines may be reached as soon as next week. But the critics keep piling up.
A handful of pharma advocacy and lobbying groups — including the International Federation of Pharmaceutical Manufacturers and Associations and the Washington Council on…
